PubMed Health⌕ Search

Biomedical subjects

L Perotti

Publications and source records attributed to L Perotti.

26 records · Page 2Linked to original sources
PubMedDate not supplied

[Asymptomatic cholelithiasis: indications for cholecystectomy based on the levels of acute phase proteins].

Prophylactic cholecystectomy for asymptomatic gallstones is still controversial. Aim of the study was to assess whether the determination of serum acute phase proteins (APP) could be utilized as a criterion for cholecystectomy, as they are suggestive of the presence in the blood of cytokines released from the inflamed gallbladder wall, even when clinical signs are missing. In 75 cases of gallstones, free from other coexistent inflammatory processes, red cell sedimentation rate, plasmatic cortisol, immunoglobulin (IgA, IgG, IgM), electrophoresis of the proteins, CPR, fibrinogen, haptoglobin, alfa-1-antitrypsin and bile culture have been detected. The patients have been subdivided into two groups: patients with asymptomatic or mildly symptomatic disease and patients with a clear clinical pattern of acute cholecystitis. In the latter alfa-1-globulin, alfa-2-globulin, ESR, CPR and cortisol turned out to be significantly elevated, while in 20-30% of the former CPR, beta-globulin and cortisol were increased, too. The study demonstrates that among the patients with asymptomatic gallstones there is a population having PFA values higher than normal. This is suggestive of a cytokines activation which, when other inflammatory processes can be excluded, is likely due to gallbladder inflammation and surgery will likely be indicated.

Acute-Phase Proteins↗
PubMedDate not supplied

Effects of physiological concentrations of steroid hormones and interleukin-11 on basal and stimulated production of interleukin-8 by human osteoblast-like cells with different functional profiles.

OBJECTIVE: IL-8 is a CXC chemokine involved in the pathogenesis of articular damage in rheumatoid arthritis. Local hyperproduction of IL-8 has been suggested to play a role in subchondral bone loss, since it suppresses osteoblast activity and promotes osteoclasts recruitment. Osteoblasts are a source of IL-8; its secretion is regulated by a number of hormones and cytokines. The aim of the present study was to evaluate the single and combined effects of physiological concentrations of cortisol, 17 beta-estradiol and IL-11 upon basal and IL-1 beta-inducible production of IL-8 in two human osteoblast-like cell lines, Saos-2 and MG-63. METHODS: Cells were incubated with cortisol (0.01 to 1 microM), 17 beta-estradiol (10 to 1000 pg/ml), IL-11 (1 to 100 ng/ml), in presence or absence of IL-1 beta (10 ng/ml), for 20 h. Combinations of 17 beta-estradiol and cortisol, and of IL-11 and cortisol, were also tested. After incubation, IL-8 levels in supernatants were measured by ELISA. RESULTS: Cortisol dose-dependently inhibited spontaneous IL-8 secretion in both cell lines, although statistical significance was attained in the MG-63 cells only (P < 0.01); no effect of 17 beta-estradiol was apparent. With regard to IL-1 beta-inducible production, cortisol dose-dependently inhibited IL-8 release in both cell lines (P < 0.01); 17 beta-estradiol resulted in only a non-significant decrease in Saos-2, but not in MG-63 cells. 17 beta-estradiol did not alter the effects of cortisol in experiments involving co-incubation. IL-11 did not have any effect on spontaneous IL-8 release, but exerted a significant inhibitory effect on IL-1 beta-inducible release in MG-63 cells (P < 0.05); no additional effect was observed upon the degree of cortisol-dependent inhibition. CONCLUSION: Cortisol is a potent physiological inhibitor of IL-8 production by osteoblast-like cells. The results of the present study support the use of exogenous supplemental glucocorticoids to prevent the deleterious effects of excess IL-8. The estrogenic milieu and local concentrations of IL-11 have little if any effect on the IL-8-dependent mechanisms of disease.

Cell Line, Tumor↗
PubMedDate not supplied

Endocrine profiles of sows during the oestrous cycle.

We measured the plasma concentrations of luteinizing hormone (LH), oestradiol (E2), progesterone (P), 17 alpha-hydroxy progesterone (17P), androstenediona (A) and testosterone (T) at oestrus and during the oestrous cycle for four consecutive cycles in a group of 15 normal sows. The results show that at oestrus the peak LH value was preceded, 24 hours earlier, by an E2 peak, and indicate that the LH rise begins when E2 concentrations reach their highest value. During diestrus, concentrations of LH and E2 were constantly low, P and 17P were characterized by lowest concentrations during the oestrous period which showed significant (p less than 0.001), progressive increases from the second day after the LH ovulatory peak, to reach their highest values after 8-14 days. The 17P decrease in proestrus precedes that of P.T and A concentrations showed a significant (p less than 0.001) increase 2 days before the LH ovulatory peak; high plasma concentrations of both androgens were maintained until the LH peak occurred. Measurements taken in consecutive cycles in the same animals showed a high reproducibility of the hormone concentrations examined, which showed similar patterns and values in each of the cycles studied. This high reproducibility suggests that these hormones have an important physiological role and may affect oestrous behaviour.

Androstenedione↗
PubMedDate not supplied

Effects of different amounts of LH on superovulation induction with long-acting GnRH in an IVF program.

OBJECTIVE: To evaluate whether different doses of exogenous LH affect IVF outcome. DESIGN: Retrospective analysis of two consecutive trials. SETTING: Infertility Unit of 1st Department of Obstetrics and Gynecology, University of Milan, Italy. PATIENTS: Two groups of 40 eumennorrheic patients matched for age and indications for in vitro fertilization. INTERVENTION: After suppression with a GnRH analogue, both groups received equal amounts of FSH in the first five days of stimulation; after this, the proportions of LH administered were doubled in one group because a different preparation was in use. MAIN OUTCOME MEASURES: The following observations were compared: number of scans (days to hCG), number of oocytes retrieved, fertilization rate, quality and number of embryos transferred, pregnancy and abortion rate. RESULTS: Doubling the amount of LH administered does not affect any outcome measure except the number of days of stimulation needed prior to hCG administration. CONCLUSIONS: No significant difference was seen in terms of number of oocytes, embryo number and quality, pregnancy and abortion rate. The only difference was the length of the stimulation phase.

Abortion, Induced↗